Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ГБОУ ДПО Пензенский институт усовершенствования врачей Минздрава России; 2ГБУЗ Областная психиатрическая больница им. К.Р.Евграфова, Пенза
Список исп. литературыСкрыть список 1. Rief W, Isaac M. Are somatoform disorders «mental disorders»? A contribution to the current debate. Curr Opin Psychiatry 2007; 20 (2): 143–6. 2. Иванов С.В. Соматоморфные расстройства (органные неврозы): эпидемиология, коморбидные психосоматические соотношения, терапия. Автореф. дис. … д-ра мед. наук. М., 2002. 3. Холмогорова А.Б., Гаранян Н.Г. Соматизация: современные трактовки, психологические модели и методы психотерапии. Часть 1. Соврем. терапия психических расстройств. 2008; 2: 31–5. 4. Woolfolk RL, Allen LA. Somatization: epidemiology, clinical characteristics and treatment. In: Woolfolk RL, Allen LA. Treating somatization: a cognitive-behavioral approach. The Guilford Press, 2007; p. 46–65. 5. Simon GE, VonKorff M, Piccinelli M et al. An international study of the relation between somatic symptoms and depression. N Engl J Med 1999; 341 (18): 1329–35. 6. Lecrubier Y. Physical components of depression and psychomotor retardation. J Clin Psychiatry 2006; 67 (6): 23–6. 7. Löwe B, Spitzer RL, Williams JB et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008; 30 (3): 191–9. 8. Clarke DM, Piterman L, Byrne CJ, Austin DW. Somatic symptoms, hypochondriasis and psychological distress: a study of somatisation in Australian general practice. Med J Aust 2008; 189 (10): 560–4. 9. Jackson J, Fiddler M, Kapur N et al. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology and gastroenterology clinics. J Psychosom Res 2006; 60: 357–63. 10. Jackson JL, Passamonti M. The outcomes among patients presenting in primary care with a physical symptom at 5 years. J Gen Intern Med 2005; 20 (11): 1032–7. 11. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001; 51: 361–7. 12. Simon GE et al. Are somatoform disorders a distinct category? In: Maj M, Akiskal HS, Mezzich JE et al (eds). Somatoform disorders. Chichester: Wiley, 2005; p. 29–31. 13. Creed F. Should general psychiatry ignore somatization and hypochondriasis? World Psychiatry 2006; 5 (3): 146–50. 14. Андрющенко А.В. Психические и психосоматические расстройства в учреждениях общесоматической сети (клинико-эпидемиологические аспекты, психосоматические соотношения, терапия). Автореф. дис. … д-ра мед. наук. М., 2011. 15. De Waal MW, Arnold IA, Eekhof JA, Van Hemert AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatr 2004; 184: 470–6. 16. Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics 2011; 52 (3): 263–71. 17. Toft T, Fink P, Oernboel E et al. Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the functional illness in primary care (FIP) study. Psychol Med 2005; 35 (8): 1175–84. 18. Escobar JI, Cook B, Chen CN et al. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. J Psychosom Res 2010; 69 (1): 1–8. 19. Hiller W, Rief W, Brähler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 2006; 41: 704–12. 20. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–76. 21. Gili M, Luciano JV, Serrano MJ et al. Mental disorders among frequent attenders in primary care: a comparison with routine attenders J Nerv Ment Dis 2011; 199 (10): 744–9. 22. Schmitz N, Kruse J. The relationship between mental disorders and medical service utilization in a representative community sample. Soc Psychiatry Psychiatr Epidemiol 2002; 37 (8): 380–6. 23. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007; 69: 881–8. 24. Fink P, Burton C, de Bie J et al. Current state of management and organisation of care. In: Creed F, Henningsen P, Fink P (eds). Medically unexplained symptoms, somatisation and bodily distress: developing better clinical services. Cambridge: Cambridge University Press, 2011; p. 97–124. 25. Decoutere L, van den Eede F, Moorkens G, Sabbe BG. Antipsychotic agents in the treatment of somatoform disorders; a review. Tijdschr Psychiatr 2011; 53 (3): 163–73. 26. Somashekar B, Jainer A, Wuntakal B. Psychopharmacotherapy of somatic symptoms disorders. Int Rev Psychiatry 2013; 25 (1): 107–15. 27. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007; 69: 889–900. 28. Morriss R. Role of mental health professionals in the management of functional somatic symptoms in primary care. Br J Psychiatry 2012; 200 (6): 444–5. 29. Voigt K, Nagel A, Meyer B et al. Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psychosom Res 2010; 68 (5): 403–14. 30. Антохин Е.Ю. Опыт применения шкалы SCL-90-R в психодиагностике невротических расстройств позднего возраста. Психиатрия и психофармакотерапия. 2005; 2: 89–91. 31. Опросник выраженности психопатологической симптоматики (Simptom Check List-90-Revised – SCL-90-R). Практикум по психологии посттравматического стресса. Под ред. Н.В.Тарабриной. СПб.: Питер, 2001; с. 146–81. 32. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale – preliminary report. Psychopharmacol Bull 1973; 9 (1): 13–28. 33. Gartlehner G, Thieda P, Hansen RA et al. Comparative risk for harms of second-generation antidepressants: a systematic review and meta-analysis. Drug Saf 2008; 31 (10): 851–65. 34. Meijer WE, Heerdink ER, van Eijk JT, Leufkens HG. Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands. Pharmacoepidemiol Drug Saf 2002; 11 (8): 655–62. 35. Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry 1988; 145 (11): 1358–68.